Advertisement

Topics

Ironwood's gout-related hyperuricemia drug wins FDA nod

05:23 EDT 22 Aug 2017 | SmartBrief

Ironwood Pharmaceuticals' Duzallo, or lesinurad and allopurinol, was approved by the FDA as a treatment for hyperuricemia in  -More

Original Article: Ironwood's gout-related hyperuricemia drug wins FDA nod

NEXT ARTICLE

More From BioPortfolio on "Ironwood's gout-related hyperuricemia drug wins FDA nod"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Gout
According to the National Arthritis Data Workgroup, an estimated 6 million people in the United States report having experienced gout at some point in their lives. In fact, gout is the most common form of inflammatory arthritis in men over the age of 40....